NM_014363.6(SACS):c.6126C>A (p.Cys2042Ter) AND Charlevoix-Saguenay spastic ataxia
- Germline classification:
- Pathogenic (1 submission)
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001391622.1
Allele description [Variation Report for NM_014363.6(SACS):c.6126C>A (p.Cys2042Ter)]
NM_014363.6(SACS):c.6126C>A (p.Cys2042Ter)
Condition(s)
-
Cfpac1 cells, RNAseq Trametinib 3h, Rep2
Cfpac1 cells, RNAseq Trametinib 3h, Rep2biosample
-
Cfpac1 cells, RNAseq Untreated, Rep1
Cfpac1 cells, RNAseq Untreated, Rep1biosample
-
membrane glycoprotein US3 [Human betaherpesvirus 5]
membrane glycoprotein US3 [Human betaherpesvirus 5]gi|52139315|ref|YP_081590.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 3, 2024